Канал: Syenza

Medicare Price Cuts: The Hidden Impact on Healthcare Innovation

Medicare Price Cuts: The Hidden Impact on Healthcare Innovation

Personalized Medicine: Navigating Challenges in the Era of Fast-Track Approvals

Personalized Medicine: Navigating Challenges in the Era of Fast-Track Approvals

Foundations of Health Economics: William Petty

Foundations of Health Economics: William Petty

Quantifying Fair Pricing: A Step Towards Global Economic Policy

Quantifying Fair Pricing: A Step Towards Global Economic Policy

Enhancing Medicine Pricing Transparency

Enhancing Medicine Pricing Transparency

The Unknown Risks of Extreme Policies in Medicine Price Transparency

The Unknown Risks of Extreme Policies in Medicine Price Transparency

Health Technology Assessments: Barriers and Opportunity Costs

Health Technology Assessments: Barriers and Opportunity Costs

Fair Pricing of Rare Disease Medicines

Fair Pricing of Rare Disease Medicines

4th Fair Pricing Forum: Improving Market Transparency of Health Products

4th Fair Pricing Forum: Improving Market Transparency of Health Products

4th Fair Pricing Forum: Negotiating Fair Pricing – Opportunities, Powers, and Promises

4th Fair Pricing Forum: Negotiating Fair Pricing – Opportunities, Powers, and Promises

The 4th Fair Pricing Forum (WHO)

The 4th Fair Pricing Forum (WHO)

Ensuring Model Integrity: The Critical Role of Validation in Modeling

Ensuring Model Integrity: The Critical Role of Validation in Modeling

Exploring HTAi's Rare Diseases Interest Group: Innovative Projects and Key Insights

Exploring HTAi's Rare Diseases Interest Group: Innovative Projects and Key Insights

PhRMA's Social Determinants of Health (SDOH)

PhRMA's Social Determinants of Health (SDOH)

HEOR Core Competencies

HEOR Core Competencies

Decoding Research Integrity: Assessing the Quality of Studies in Peer-Reviewed Journals

Decoding Research Integrity: Assessing the Quality of Studies in Peer-Reviewed Journals

Decoding Research Integrity: Cohort, Case-Control, Cross-Sectional Studies

Decoding Research Integrity: Cohort, Case-Control, Cross-Sectional Studies

Decoding Research Integrity Hierarchy of Evidence and Randomised Control Trials

Decoding Research Integrity Hierarchy of Evidence and Randomised Control Trials

Decoding Research Integrity: A Deep Dive into Evaluating Scientific Papers!

Decoding Research Integrity: A Deep Dive into Evaluating Scientific Papers!

Transforming Healthcare: Indonesia's NHI Success Story and Lessons for the World

Transforming Healthcare: Indonesia's NHI Success Story and Lessons for the World

Unlocking the Future of Healthcare: The Power of National Health Insurance in South Africa

Unlocking the Future of Healthcare: The Power of National Health Insurance in South Africa

Challenges and Promising Developments in GLP-1 Therapies for Diabetic Patients in South Africa

Challenges and Promising Developments in GLP-1 Therapies for Diabetic Patients in South Africa

Artificial Intelligence in healthcare is transforming how we tackle challenges

Artificial Intelligence in healthcare is transforming how we tackle challenges

The global shortage of GLP1 drugs, such as Ozempic and Wegovy

The global shortage of GLP1 drugs, such as Ozempic and Wegovy

South Africa's Vaccine Dilemma: Saving Money or Supporting Innovation?

South Africa's Vaccine Dilemma: Saving Money or Supporting Innovation?

Health Technology Assessment Coordination Group subgroups

Health Technology Assessment Coordination Group subgroups

PART 4/4: Health Technology Assessment Methods Guide (South Africa): Technical Issues in the Guide

PART 4/4: Health Technology Assessment Methods Guide (South Africa): Technical Issues in the Guide

PART 3/4: Health Technology Assessment Methods Guide (South Africa): Supply & Demand for Skills

PART 3/4: Health Technology Assessment Methods Guide (South Africa): Supply & Demand for Skills

PART 2/4: Health Technology Assessment Methods Guide (South Africa): Cost-Benefit Analysis of HTA

PART 2/4: Health Technology Assessment Methods Guide (South Africa): Cost-Benefit Analysis of HTA

PART 1/4: Health Technology Assessment Methods Guide (South Africa): Who Funded it and Why?

PART 1/4: Health Technology Assessment Methods Guide (South Africa): Who Funded it and Why?

Economic Burden of Antimicrobial Resistance (HIQA, Ireland)

Economic Burden of Antimicrobial Resistance (HIQA, Ireland)

Buybacks, Dividends, Executive Compensation in the Pharmaceutical Industry

Buybacks, Dividends, Executive Compensation in the Pharmaceutical Industry

Does COVID cause diabetes, or is it a case of BAD science?

Does COVID cause diabetes, or is it a case of BAD science?

Prices and Affordability of Cancer Medicines in EU and LATAM

Prices and Affordability of Cancer Medicines in EU and LATAM

Strategies to improve pharmaceutical supply chain in Iran.

Strategies to improve pharmaceutical supply chain in Iran.

Access to Cancer Medicines in South Africa - Cancer Alliance

Access to Cancer Medicines in South Africa - Cancer Alliance

Board of Healthcare Funders Annual Report 2020 & Biosimilars in Europe.

Board of Healthcare Funders Annual Report 2020 & Biosimilars in Europe.

Sotrovimab in the UAE & HOPE Consortium: COVID-19 Vaccine Global Distribution

Sotrovimab in the UAE & HOPE Consortium: COVID-19 Vaccine Global Distribution

PBS Australia National Medicines Policy, Medscheme Medicines Management, Biosimilars in Belgian

PBS Australia National Medicines Policy, Medscheme Medicines Management, Biosimilars in Belgian

Medtronic Case Study: VBHC Implementation and Lessons Learnt

Medtronic Case Study: VBHC Implementation and Lessons Learnt

Bupa Arabia: The Rising Burden of Medication in Kingdom of Saudi Arabia.

Bupa Arabia: The Rising Burden of Medication in Kingdom of Saudi Arabia.

World Health Organisation Fair Pricing & Board of Healthcare Funders, Alternative Reimbursement

World Health Organisation Fair Pricing & Board of Healthcare Funders, Alternative Reimbursement

VBHC Webinar Series: Paul van der Nat

VBHC Webinar Series: Paul van der Nat

Applied Pharmacoeconomics in Norway with Kristin Svanqvist

Applied Pharmacoeconomics in Norway with Kristin Svanqvist

Applied Pharmacoeconomics in The Netherlands with Bart van den Bemt

Applied Pharmacoeconomics in The Netherlands with Bart van den Bemt

Trevor Landry: Vice President Market Access, Novo Nordisk Region Europe.

Trevor Landry: Vice President Market Access, Novo Nordisk Region Europe.

Prof. Mark Sonderup: Division of Hepatology, University of Cape Town, South Africa.

Prof. Mark Sonderup: Division of Hepatology, University of Cape Town, South Africa.

Dr. Felipe Ades: Medical Oncologist, Hospital Albert Einstein, Brasil.

Dr. Felipe Ades: Medical Oncologist, Hospital Albert Einstein, Brasil.

Unified Thinking on COVID-19: Rare Disease Patients and Organizations with Kelly du Plessis

Unified Thinking on COVID-19: Rare Disease Patients and Organizations with Kelly du Plessis

C&C Global, Inc

C&C Global, Inc

Unified Thinking on COVID-19: Pharmacy Practice and Education with Prof Zubin Austin

Unified Thinking on COVID-19: Pharmacy Practice and Education with Prof Zubin Austin

Unified Thinking on Covid-19: Food Security with Prof Chris Bosso

Unified Thinking on Covid-19: Food Security with Prof Chris Bosso

Unified Thinking on COVID 19: Ethical Implications with Udo Schuklenk

Unified Thinking on COVID 19: Ethical Implications with Udo Schuklenk

Pharmacoeconomics for Working Professionals

Pharmacoeconomics for Working Professionals

Decision Modelling for Pharmacoeconomic Evaluations

Decision Modelling for Pharmacoeconomic Evaluations

Anne-Toni Rodgers: Global Lead Payer and RWE, AstraZeneca

Anne-Toni Rodgers: Global Lead Payer and RWE, AstraZeneca

Reg Waldeck: VP Access, Pricing and Health Economics, Celldex Therapeutics

Reg Waldeck: VP Access, Pricing and Health Economics, Celldex Therapeutics

Barbara Jaszewski - VP, Global Pricing and Market Access, Lundbeck

Barbara Jaszewski - VP, Global Pricing and Market Access, Lundbeck

Unified Thinking on COVID-19: Vaccine Development

Unified Thinking on COVID-19: Vaccine Development

Clinical Value Assessment - USA Application and Experience

Clinical Value Assessment - USA Application and Experience

Did you know? Since 2007 we have ...

Did you know? Since 2007 we have ...

Brazil is incorporating new health technologies in the health system. What is the main challenge?

Brazil is incorporating new health technologies in the health system. What is the main challenge?

National Health Insurance in South Africa

National Health Insurance in South Africa

Pharmacoeconomic Guidelines in South Africa (A Comparative Review) - ISPOR South Africa Panel

Pharmacoeconomic Guidelines in South Africa (A Comparative Review) - ISPOR South Africa Panel

Pharmacoeconomic Guidelines in South Africa (A Comparative Review)

Pharmacoeconomic Guidelines in South Africa (A Comparative Review)

What makes a good systematic review and meta-analysis?

What makes a good systematic review and meta-analysis?

C&C Webinar: What makes a great paper?

C&C Webinar: What makes a great paper?

Market Access Strategies to Boost Access to Innovative Treatments

Market Access Strategies to Boost Access to Innovative Treatments

Dr Joao Carapinha | MENA Health Insurance

Dr Joao Carapinha | MENA Health Insurance

Interview with Prof. Liliya Ziganshina

Interview with Prof. Liliya Ziganshina

BRICS Medicines Alliance Discussion Series

BRICS Medicines Alliance Discussion Series

Market Access in Emerging Markets - Unmet Need and Growth Potential

Market Access in Emerging Markets - Unmet Need and Growth Potential